Trevi Therapeutics (TRVI) CFO reports Form 3 showing no stock

Rhea-AI Filing Summary

Trevi Therapeutics, Inc. executive David C. Hastings, the company’s Chief Financial Officer, filed an initial Form 3 ownership report as of 01/08/2026.

The filing indicates that he has no securities beneficially owned in Trevi Therapeutics, with both the non-derivative and derivative securities tables showing no holdings. A power of attorney (Exhibit 24.1) authorizes attorney-in-fact Christopher Galletta to sign the form on his behalf.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

HASTINGS DAVID C

(Last) (First) (Middle)

C/O TREVI THERAPEUTICS, INC.

195 CHURCH STREET, 16TH FLOOR

(Street)

NEW HAVEN CT 06510

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/08/2026

3. Issuer Name and Ticker or Trading Symbol
Trevi Therapeutics, Inc. [ TRVI ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit Index: 24.1 Power of Attorney

No securities are beneficially owned.

	/s/ Christopher Galletta, attorney-in-fact	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Trevi Therapeutics (TRVI) disclose in this Form 3 filing?

The Form 3 shows that Chief Financial Officer David C. Hastings currently has no securities beneficially owned in Trevi Therapeutics, Inc.

Who is the reporting person in Trevi Therapeutics (TRVI) Form 3?

The reporting person is David C. Hastings, who is identified as an officer of Trevi Therapeutics, serving as Chief Financial Officer.

What is the event date for the Trevi Therapeutics (TRVI) Form 3?

The Form 3 lists the Date of Event Requiring Statement as 01/08/2026.

Does the Trevi Therapeutics (TRVI) CFO own any non-derivative or derivative securities?

No. The filing states in the remarks that no securities are beneficially owned, and the tables for non-derivative and derivative securities show no holdings.

Who signed the Trevi Therapeutics (TRVI) Form 3 on behalf of the CFO?

The Form 3 is signed by /s/ Christopher Galletta as attorney-in-fact, pursuant to a Power of Attorney listed as Exhibit 24.1.

Is this Trevi Therapeutics (TRVI) Form 3 filed by one or multiple reporting persons?

The document indicates that it is a Form filed by One Reporting Person, referring to David C. Hastings.